1. Home
  2. MMYT vs RGEN Comparison

MMYT vs RGEN Comparison

Compare MMYT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MakeMyTrip Limited

MMYT

MakeMyTrip Limited

HOLD

Current Price

$63.97

Market Cap

7.8B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$164.10

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMYT
RGEN
Founded
2000
1981
Country
India
United States
Employees
N/A
N/A
Industry
Transportation Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.2B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
MMYT
RGEN
Price
$63.97
$164.10
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$106.33
$177.18
AVG Volume (30 Days)
1.3M
590.3K
Earning Date
01-21-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.53
0.03
Revenue
$1,039,337,000.00
$707,890,000.00
Revenue This Year
$17.65
$17.86
Revenue Next Year
$17.64
$12.44
P/E Ratio
$120.11
$6,419.08
Revenue Growth
11.07
11.74
52 Week Low
$62.01
$102.97
52 Week High
$120.73
$182.52

Technical Indicators

Market Signals
Indicator
MMYT
RGEN
Relative Strength Index (RSI) 25.26 46.62
Support Level $62.01 $160.22
Resistance Level $75.13 $174.87
Average True Range (ATR) 3.04 6.84
MACD -1.83 -0.67
Stochastic Oscillator 8.80 27.39

Price Performance

Historical Comparison
MMYT
RGEN

About MMYT MakeMyTrip Limited

MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: